45 related articles for article (PubMed ID: 6398768)
1. From evidence to practice: development of web-based Dutch lipid reference values.
Nurmohamed NS; Collard D; Balder JW; Kuivenhoven JA; Stroes ESG; Reeskamp LF
Neth Heart J; 2021 Sep; 29(9):441-450. PubMed ID: 33844162
[TBL] [Abstract][Full Text] [Related]
2. Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.
Celik F; Huitema AD; Hooijberg JH; van de Laar AW; Brandjes DP; Gerdes VE
Obes Surg; 2015 Apr; 25(4):628-34. PubMed ID: 25223871
[TBL] [Abstract][Full Text] [Related]
3. Quality assessment of the genetic test for familial hypercholesterolemia in the Netherlands.
Kindt I; Huijgen R; Boekel M; van der Gaag KJ; Defesche JC; Kastelein JJ; de Knijff P
Cholesterol; 2013; 2013():531658. PubMed ID: 23936638
[TBL] [Abstract][Full Text] [Related]
4. Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.
Huijgen R; Kindt I; Verhoeven SB; Sijbrands EJ; Vissers MN; Kastelein JJ; Hutten BA
PLoS One; 2010 Feb; 5(2):e9220. PubMed ID: 20169164
[TBL] [Abstract][Full Text] [Related]
5. The new heart failure diet: less salt restriction, more micronutrients.
Rothberg MB; Sivalingam SK
J Gen Intern Med; 2010 Oct; 25(10):1136-7. PubMed ID: 20151221
[No Abstract] [Full Text] [Related]
6. Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia.
Monk JP; Todd PA
Drugs; 1987 Jun; 33(6):539-76. PubMed ID: 3301301
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
[TBL] [Abstract][Full Text] [Related]
8. A comparative review of the adverse effects of treatments for hyperlipidaemia.
Steiner A; Weisser B; Vetter W
Drug Saf; 1991; 6(2):118-30. PubMed ID: 2043283
[TBL] [Abstract][Full Text] [Related]
9. Effect of psyllium hydrophilic mucilloid on serum cholesterol in the elderly.
Stewart RB; Hale WE; Moore MT; May FE; Marks RG
Dig Dis Sci; 1991 Mar; 36(3):329-34. PubMed ID: 1995270
[TBL] [Abstract][Full Text] [Related]
10. Value and safety of diet modification to control hyperlipidemia in childhood and adolescence. A statement for physicians. Ad Hoc Committee of the Steering Committee for Medical and Community Program of the American Heart Association.
Glueck CJ; McGill HC; Shank RE; Lauer RM
Circulation; 1978 Aug; 58(2):381A-385A. PubMed ID: 668092
[TBL] [Abstract][Full Text] [Related]
11. Regression of atherosclerosis: dietary and pharmacologic approach.
Blankenhorn DH
Can J Cardiol; 1989 May; 5(4):206-10. PubMed ID: 2659149
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of primary hyperlipidemia in childhood. A Joint Statement for Physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council of Cardiovascular Disease in the Young and the Nutrition Committee, American Heart Association.
Circulation; 1986 Nov; 74(5):1181A-1188A. PubMed ID: 3769175
[No Abstract] [Full Text] [Related]
13. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis.
Gotto AM; Bierman EL; Connor WE; Ford CH; Frantz ID; Glueck CJ; Grundy SM; Little JA
Circulation; 1984 May; 69(5):1065A-1090A. PubMed ID: 6398768
[No Abstract] [Full Text] [Related]
14. Recommendations for the treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis of the American Heart Association.
Arteriosclerosis; 1984; 4(4):443A-468A. PubMed ID: 6466199
[No Abstract] [Full Text] [Related]
15. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
Circulation; 1984 May; 69(5):1067A-1090A. PubMed ID: 6368042
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
